Community Research and Development Information Service - CORDIS

Results 1 - 10 of 189
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
QUantitative Imaging in Cancer: CONnecting CEllular Processes with Therapy
ID: 115151
Start date: 2011-09-01, End date: 2017-12-31
The QuIC-ConCePT consortium has 2 objectives: 1.(90% of resource, WP2-5) to qualify 3 specific imaging biomarkers (IBs) of tumour cell proliferation, apoptosis, and necrosis, to allow drug developers to demonstrate reliably modulation of these pathologic processes in tumours ...
Programme: FP7-JTI
Record Number: 203689
Last updated on: 2018-01-22
Kinetics for Drug Discovery (K4DD)
ID: 115366
Start date: 2012-11-01, End date: 2017-10-31
There is mounting evidence that the often ignored kinetic aspects of the interaction between a drug and its target are highly relevant for clinical success. This ignorance may be one of the reasons for the high attrition rates in drug discovery, as it has been analyzed that m...
Programme: FP7-JTI
Record Number: 203705
Last updated on: 2018-01-22
Biomarkers For Enhanced Vaccine Safety
ID: 115308
Start date: 2012-03-01, End date: 2018-02-28
BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised into focused Activity Cores to generate knowledge and tools to benchmark licensed vaccine reactogenicity, and create practical and gene...
Programme: FP7-JTI
Record Number: 203698
Last updated on: 2018-01-15
European Bank for induced pluripotent Stem Cells
ID: 115582
Start date: 2014-01-01, End date: 2017-12-31
EBiSC is designed to address the increasing demand by iPSC researchers for quality-controlled, disease-relevant research grade iPSC lines, data and cell services. Its goal is to demonstrate an operational banking and distribution service of iPSC lines after 3 years and to est...
Programme: FP7-JTI
Record Number: 203673
Last updated on: 2018-01-08
Aetionomy – Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and Therapy
ID: 115568
Start date: 2014-01-01, End date: 2018-12-31
IMI’s Call 8 is geared to develop knowledge frameworks for ‘druggable mechanisms’ for two domains of pathophysiology. In response to this call, we propose (I) the development of a generic AETIONOMY pipeline to capture and infer over mechanistic knowledge of pathophysiology, a...
Programme: FP7-JTI
Record Number: 203715
Last updated on: 2018-01-08
European Medical Information Framework
ID: 115372
Start date: 2013-01-01, End date: 2018-06-30
In response to the need to tackle increasingly complex medical research questions, a growing amount of human health data is being collected, either in routine Electronic Healthcare Record (EHR) databases, through research-driven cohort studies, in biobanks or related efforts....
Programme: FP7-JTI
Record Number: 203707
Last updated on: 2018-01-08
Thermochemical HYDROgen production in a SOLar monolithic reactor: construction and operation of a 750 kWth PLANT
ID: 325361
Start date: 2014-01-01, End date: 2018-04-30
The HYDROSOL-PLANT project is expected to develop, verify and operate all of the tools required to scale up solar H2O splitting to the pilot (750 kWth) scale. The work will be based on the successful HYDROSOL series projects and mainly on the outcome of the current FCH-JU co-...
Programme: FP7-JTI
Record Number: 111501
Last updated on: 2018-01-03
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk
ID: 115303
Start date: 2012-03-01, End date: 2018-02-28
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia...
Programme: FP7-JTI
Record Number: 203697
Last updated on: 2017-12-18
Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection
ID: 115672
Start date: 2015-03-01, End date: 2020-02-29
Background: Influenza viruses cause annual epidemic and occasional pandemics, both of which induce significant morbidity and mortality. Influenza infections affect all age groups but children and adults over the age of 65 are at most risk of developing severe disease. Vaccina...
Programme: FP7-JTI
Record Number: 203720
Last updated on: 2017-12-18
Accelerated Development of Vaccine benefit-risk  Collaboration in Europe
ID: 115557
Start date: 2013-10-01, End date: 2018-09-30
Aim: The ADVANCE vision is focused on Timely and Best Evidence on Vaccine Effects. Our mission is to establish a best practice framework to rapidly provide robust data on vaccine benefits and risks to support accelerated decision-making. Approach: To achieve this vision throu...
Programme: FP7-JTI
Record Number: 203713
Last updated on: 2017-12-18
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2018-07-21
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top